Related Experiment Video
Updated: Aug 25, 2025

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Progression of Myopic Maculopathy: A Systematic Review and Meta-Analysis
Motohiro Itoi1, Osamu Hieda, Natsuki Kusada
1Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Purpose:
The purpose of this study was to elucidate the risk factors for the progression of myopic maculopathy (MM) based on severity.
Methods:
In this study, we conducted a systematic review and meta-analysis of the literature published before December 2020 on the risk factors for the progression of MM in patients with pathologic myopia (PM) and high myopia (HM). Odds ratios (ORs) for different stages of myopic maculopathy categorized based on the International Meta-Analysis for PM (META-PM) classification were calculated using fixed and random effects models.
Results:
A total of 12,070 affected eyes derived from 5 cohort studies were included in the systematic review. The presence of PM at baseline was found to be significantly associated with an increased risk of MM progression (pooled ORs: 7.17, 95% confidence interval [CI]: 3.29-15.6), and the greater category of MM at baseline was found to be significantly associated with an increased risk of MM progression, that is, eyes with MM category 3 or more compared with eyes with MM category 2 (pooled OR: 10.95, 95% CI: 6.07-19.76) and eyes with MM category 4 compared with eyes with MM category 3 (pooled ORs: 2.45, 95% CI: 0.28-21.37).
Conclusions:
The findings in this systematic review and meta-analysis indicate that the progression of MM is associated with more severe MM at baseline.
Insights
The progression of myopic maculopathy (MM) is linked to its baseline severity. Pathologic myopia (PM) at baseline significantly increases the risk of MM progression, highlighting severity as a key factor.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Myopia Research
Background:
- Myopic maculopathy (MM) is a leading cause of visual impairment in patients with pathologic myopia (PM) and high myopia (HM).
- Understanding risk factors for MM progression is crucial for timely intervention and management.
- Previous studies have explored various risk factors, but a comprehensive analysis based on MM severity is needed.
Approach:
- A systematic review and meta-analysis of cohort studies published before December 2020 was conducted.
- Risk factors for MM progression in patients with PM and HM were analyzed.
- Odds ratios (ORs) for MM progression were calculated across different severity stages using the META-PM classification.
Key Points:
- Pathologic myopia (PM) at baseline significantly elevates the risk of MM progression (pooled OR: 7.17).
- Greater baseline myopic maculopathy (MM) severity is strongly associated with increased MM progression.
- Eyes with MM category 3 or higher showed a substantially increased risk of progression compared to category 2 (pooled OR: 10.95).
Conclusions:
- The progression of myopic maculopathy (MM) is significantly associated with its baseline severity.
- Early detection and monitoring of MM severity are critical for predicting and managing disease progression.
- These findings underscore the importance of the META-PM classification in assessing MM progression risk.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

